Khasraw, Mustafa, Lee, Adrian, McCowatt, Sally, Kerestes, Zoltan, Buyse, Marc E., Back, Michael, Kichenadasse, Ganessan, Ackland, Stephen, Wheeler, Helen. Springer; 2016. Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial.